Humachag, Jea G.
HRN: 05-93-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/29/2024
CEFAZOLIN 1GM (VIAL)
02/29/2024
02/29/2024
IV
1 Gram
Q8hours
Open Fracture Right Patella
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes